KURA ONE, Compact Cans of Japanese Sake Featuring Brands From Award-winning Sake Breweries in Japan and Overseas, Is Now Available as a Subscription Service Delivered Worldwide!
28.2.2023 11:00:00 EET | Business Wire | Press release
KURA ONE meticulously selects sake from brands of award-winning sake breweries in Japan and overseas and repackages them in compact and easy-to-handle 180ml/196g aluminum cans, while maintaining the quality of the sake. On January 31, the first canned sake subscription service in the world that delivers sake, along with stories about enjoying sake, directly to customers via subscription in more than 100 countries has launched online ordering. As a result of the service's introduction in numerous media sources, it has been attracting attention in Japan.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230223006067/en/
Sake breweries from different regions also participated in the press conference. (Photo: Business Wire)
“KURA ONE Sales Commemorative Special Edition,” which is a complete set of all 21 brands to be delivered from January to June 2023, and the Assortment Box with special sake containers featuring Japanese craftsmanship are very popular.
Also, KURA ONE's brand movie "KURA ONE TRIP." which introduces sake breweries and their regions is now online. On February 28 (Tue.), KURA ONE begins accepting applications worldwide for BtoB partners (restaurants, sake retailers, etc.) who can place orders for as little as 30 cans.
Video of press conference in Tokyo (English version): https://www.youtube.com/watch?v=aTTeue_Y2Ig
KURA ONE TRIP.: https://sake.japanpage.jp/en/pages/kuraone_movies
[Six new Collections. Now shipping to 100 countries around the world!]
-
“KURA ONE STORY. Subscription”: 3-4 cans of brands from domestic and international award-winning sake breweries delivered each month.
Price: 3,600 yen (tax not included) per month, limited to the first 2,000 slots - “KURA ONE Sales Commemorative Special Edition”: a special complete set of 21 cans of brands from award-winning sake breweries in Japan and overseas. Price: 23,000 yen (without tax) and limited to the first 500 sets.
- "KURA ONE Glass Sake Cup Box": includes 4 types of sake glasses of Kimoto Glassware used in famous restaurants, and 2 cans of KURA ONE. Price: 16,800 yen (without tax) and limited to the first 100 sets.
- "KURA ONE Traditional Craft Sake Cup Box": includes 3 types of traditional craft sake vessels such as Ceramic (Shigaraki) and Porcelain (Kutani) and 2 cans of KURA ONE. Price: 7,600 yen (without tax) and limited to the first 100 sets.
- "KURA ONE Temperature Sensitive Sake Cups Box": includes 2 mysterious sake vessels whose cherry blossom color changes depending on the sake temperature, and 2 cans of KURA ONE. Price: 5,400 yen (without tax) and limited to the first 100 sets.
- "KURA ONE Gacha Box": an experimental box for starters. You will enjoy 2 cans of KURA ONE after they arrive. Price: 1,700 yen (without tax)
- Shipping fees and taxes not included.
Click here to purchase (on the official website):
English: https://sake.japanpage.jp/en/pages/kuraone
French: https://sake.japanpage.jp/fr/pages/kuraone
Traditional Chinese: https://sake.japanpage.jp/zh-tw/pages/kuraone
Simplified Chinese: https://sake.japanpage.jp/zh-cn/pages/kuraone
Japanese: https://sake.japanpage.jp/pages/kuraone
[Now accepting applications for BtoB partners worldwide]
We are seeking BtoB sales partners to create new sake drinking scenes that integrate with the lifestyles of consumers in various parts of the world.
KURA ONE places importance on its target users and sales method. We will interview each company to make decisions based on the proposal content and their enthusiasm for the project, rather than on a first-come, first-served basis. This is not an exclusive offer for one company in one country. Currently, we have begun to conclude business negotiations with restaurants and sake retailers in Asia, Europe, and the United States.
Overview of BtoB sales partnerships / Transaction details / Privileges / How to apply (5 languages): https://sake.japanpage.jp/en/pages/kuraone_btob
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230223006067/en/
Contact information
KURA ONE
Public Relations: Tomoko Takiguchi
+81-80-8422-5844
info@greencreate.jp
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
VerSprite Launches Fork and Knife: AI-Driven Threat Modeling and Adversarial Testing Built for the Speed of Modern Software27.6.2026 00:28:00 EEST | Press release
VerSprite, a global leader in risk-based threat modeling and the firm behind the PASTA (Process for Attack Simulation and Threat Analysis) methodology, today announced the general availability of Fork (www.forktm.com), a continuous application threat modeling platform, alongside Knife, an AI-led, human-on-the-loop adversarial testing platform for web applications and web API endpoints. Together, the two products operationalize a new model for product security—one where applications are securely designed, continuously modeled, and actively tested as part of the build process itself. The launch addresses a problem every security leader knows but few tools have solved: threat modeling is essential, never more so than in an AI-driven era, yet it has remained slow, manual, and anchored to frameworks designed for a different threat landscape. The problem: threat modeling matters more than ever—and most tools are stuck in 2005 For two decades, application threat modeling has leaned heavily on
Venture Global Announces Closing of $1.5 Billion Senior Secured Vessel Financing Facility26.6.2026 23:30:00 EEST | Press release
Venture Global, Inc. (NYSE: VG) announced today that its wholly-owned subsidiary, Venture Global Shipping Holdings, LLC (“VGSH”), has entered into a Credit and Guaranty Agreement providing for a senior secured term loan facility (the “Facility”) in an aggregate principal amount of up to $1,500,000,000. The Facility will mature on June 26, 2032. Deutsche Bank and ING acted as coordinating lead arrangers for the Facility. ING also serves as facility agent and security trustee. VGSH intends to use the net proceeds from the Facility for general corporate purposes, including to reimburse Venture Global LNG, Inc. for payments previously made by it or its affiliates in connection with the acquisition of nine LNG carriers, funding certain reserve accounts, and paying transaction fees and expenses. About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (“LNG”) with over 100 MTPA of capacity in production, construction, or development. Ven
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release
Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom